An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 8, 2005, Pages 613-617

  Koestenberger, Martin ^a   Gallistl, Siegfried ^a   Muntean, Wolfgang ^a   Ferstl, Ulrika ^a   Kutschera, Joerg ^a   Cvirn, Gerhard ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Clot formation time; Clotting time; Maximum clot firmness; Recombinant activated factor VII; Thromboelastography; Tissue factor; Whole blood

Indexed keywords

BLOOD CLOTTING FACTOR; PROCOAGULANT; RECOMBINANT BLOOD CLOTTING FACTOR 7; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING TENDENCY; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFANT; NEWBORN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOELASTOGRAPHY; UMBILICAL CORD BLOOD;

EID: 27844505622     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000191523.79682.15     Document Type: Article

References (28)

1. Hedner U, Glazer S. Management of hemophilia patients with inhibitors. Hematol Oncol Clin North Am 1992; 6:1035-1046.
2. Negrier C, Hay CR. The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa. Semin Thromb Hemost 2000; 26:407-412.
3. Friederich PW, Geerdink MG, Spataro M, Messelink EJ, Henny CP, Buller HR, et al. The effect of the administration of recombinant activated factor VII (Novoseven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study. Blood Coagul Fibrinolysis 2000; 11:129-132.
4. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26:159-164.
5. Gallistl S, Cvirn G, Muntean W. Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost 1999; 81:245-249.
6. Mathew P. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review. Thromb Haemost 2004; 92:738-746.
7. Greisen G, Andreasen AB. Recombinant factor VIIa in preterm neonates with prolonged prothrombin time. Blood Coagul Fibrinolysis 2003; 14:117-120.
8. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70:165-172.
9. Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. Pediatrics 2002; 110:169-171.
10. Karkouti K, Beattie WS, Wijeysundera DN, Yau TM, McCluskey SA, Ghannam M, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion 2005; 45:26-34.
11. Fontaine MJ, Lazarchick J, Taylor S, Annibale D. Use of recombinant factor VIIa in infants with severe coagulopathy. J Perinatol 2004; 24:310-311.
12. Kawaguchi C, Takahashi Y, Hanesaka Y, Yoshioka A. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram. Thromb Haemost 2002; 88:768-772.
13. Gerotziafas G, Chakroun T, Depasse F, Arzoglou P, Samama M, Elalamy I. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation. Thromb Haemost 2004; 91:977-985.
14. Sorensen B, Ingerslev J. Thromboelastography and recombinant factor VIIa-hemophilia and beyond. Semin Hematol 2004; 41:140-144.
15. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2:102-110.
16. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1:551-558.
17. Engstrom M, Reinstrup P, Schott U. An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxyl ethyl starch. BMC Blood Disorders 2005; 5:3.
18. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2:1954-1959.
19. Rajwal S, Richards M, O'Meara M. The use of recalcified citrated whole blood - a pragmatic approach for thromboelastography in children. Paediatr Anaesth 2004; 14:656-660.
20. Kettner SC, Pollak A, Zimpfer M, Seybold T, Prusa AR, Herkner K, et al. Heparinase-modified thrombelastography in term and preterm neonates. Anesth Analg 2004; 98:1650-1652.
21. Hoffman M, Monroe DM. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Semin Hematol 2001; 38:6-9.
22. Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost 2003; 1:263-268.
23. Cvirn G, Gallistl S, Rehak T, Jürgens G, Muntean W. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost 2003; 1:1785-1790.
24. Shah JK, Mitchell L, Paes B, Ofosu F, Schmidt B, Andrew M. Thrombin inhibition is impaired in plasma of sick neonates. Pediatr Res 1992; 31:391-395.
25. Baier K, Cvirn G, Fritsch P, Koestenberger M, Gallistl S, Leschnik B, et al. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma. Pediatr Res 2005; 57:685-689.
26. Lang T, Toller W, Gutl M, Mahla E, Metzler H, Rehak P, et al. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004; 2:147-153.
27. Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994; 72:957-963.
28. Streif W, Paes B, Andrew M, Andreasen RB, Chan AK. Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns. Blood Coagul Fibrinolysis 2000; 11:349-357.